- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x 6CX: 5'-{[(3S)-3-amino-3-carboxypropyl][(1H-imidazol-4-yl)methyl]amino}-5'-deoxyadenosine(Non-covalent)
- 16 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.2: 4 residues within 4Å:- Chain A: Q.23, Y.24, F.27, Y.28
Ligand excluded by PLIPEDO.3: 6 residues within 4Å:- Chain A: K.151, L.154, K.155, P.156, S.157, G.158
Ligand excluded by PLIPEDO.4: 5 residues within 4Å:- Chain A: E.18, A.21, V.22, F.25, K.116
Ligand excluded by PLIPEDO.10: 5 residues within 4Å:- Chain B: Y.24, F.27, Y.28, E.141
- Ligands: EDO.12
Ligand excluded by PLIPEDO.11: 3 residues within 4Å:- Chain B: D.40, L.287, H.289
Ligand excluded by PLIPEDO.12: 8 residues within 4Å:- Chain B: M.134, G.135, Y.136, E.141, H.289, W.290
- Ligands: 6CX.9, EDO.10
Ligand excluded by PLIPEDO.13: 5 residues within 4Å:- Chain B: Y.136, V.215, Y.291, F.349, Y.351
Ligand excluded by PLIPEDO.14: 3 residues within 4Å:- Chain B: K.151, L.154, P.156
Ligand excluded by PLIPEDO.18: 3 residues within 4Å:- Chain C: D.267, W.278, S.280
Ligand excluded by PLIPEDO.19: 5 residues within 4Å:- Chain C: D.40, L.287, T.288, H.289, Y.291
Ligand excluded by PLIPEDO.20: 3 residues within 4Å:- Chain C: I.271, G.272, S.273
Ligand excluded by PLIPEDO.21: 3 residues within 4Å:- Chain C: L.52, H.55
- Ligands: PEG.22
Ligand excluded by PLIPEDO.25: 3 residues within 4Å:- Chain D: D.267, W.278, S.280
Ligand excluded by PLIPEDO.26: 3 residues within 4Å:- Chain D: Q.125, K.152, Y.153
Ligand excluded by PLIPEDO.27: 4 residues within 4Å:- Chain D: Y.24, F.27, Y.28, E.141
Ligand excluded by PLIPEDO.28: 4 residues within 4Å:- Chain D: T.173, D.174, E.175, I.222
Ligand excluded by PLIP- 7 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.5: 7 residues within 4Å:- Chain A: Q.48, L.52, Q.79
- Chain D: D.332, Q.333, T.334, G.335
No protein-ligand interaction detected (PLIP)PEG.6: 4 residues within 4Å:- Chain A: D.267, W.278, S.280, E.285
No protein-ligand interaction detected (PLIP)PEG.7: 8 residues within 4Å:- Chain A: Q.39, D.40, Y.41, L.287, T.288, H.289, Y.291, Y.351
2 PLIP interactions:2 interactions with chain A- Water bridges: A:Y.41, A:Y.41
PEG.15: 4 residues within 4Å:- Chain B: S.121, Q.125, K.152, Y.153
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:Y.153
PEG.16: 3 residues within 4Å:- Chain B: D.267, W.278, S.280
2 PLIP interactions:2 interactions with chain B- Water bridges: B:E.285, B:E.285
PEG.22: 10 residues within 4Å:- Chain B: D.332, Q.333, T.334, G.335
- Chain C: Q.48, L.52, Q.79
- Chain D: H.194, G.195
- Ligands: EDO.21
No protein-ligand interaction detected (PLIP)PEG.29: 9 residues within 4Å:- Chain D: N.36, M.37, Q.39, D.40, L.287, T.288, H.289, Y.291, Y.351
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:Y.291
- Water bridges: D:Y.41
- 1 x M2M: 1-METHOXY-2-(2-METHOXYETHOXY)ETHANE(Non-covalent)
- 1 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cura, V. et al., Crystal structure of mouse CARM1 in complex with inhibitor SA0435. To Be Published
- Release Date
- 2017-03-29
- Peptides
- Histone-arginine methyltransferase CARM1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x 6CX: 5'-{[(3S)-3-amino-3-carboxypropyl][(1H-imidazol-4-yl)methyl]amino}-5'-deoxyadenosine(Non-covalent)
- 16 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 7 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 1 x M2M: 1-METHOXY-2-(2-METHOXYETHOXY)ETHANE(Non-covalent)
- 1 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cura, V. et al., Crystal structure of mouse CARM1 in complex with inhibitor SA0435. To Be Published
- Release Date
- 2017-03-29
- Peptides
- Histone-arginine methyltransferase CARM1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D